hUC-MSC-Exosomes for T2DM - Safety & Efficacy

NCT07693036 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

BIOLOGICAL: exosomes treatment group
OTHER: control group

Sponsor

Peking University First Hospital

Collaborators

[object Object]